Developer docs
API playgroundTry for free, no card

Search company profiles

Ludocare

Full company profile

uuid0003jl1

Namestring
Ludocare
Legal namestring
LUDOCARE
Websiteurl
ludocare.com
Company typeenum
Private
Founded yearint
2017
Descriptiontext

Ludocare is a French digital health company founded in Lyon in 2017 that develops prescription digital therapeutics for children with chronic conditions, with a current focus on persistent pediatric asthma. Its flagship product, JOE, is a Class I CE-marked medical device consisting of two integrated components: a connected companion robot with an integrated screen that delivers medication reminders, guides inhalation technique via interactive multimedia content, and rewards adherence; and a parent-facing mobile application that enables individualized treatment configuration and real-time monitoring of medication intake, with optional caregiver profiles for shared monitoring. The platform is Android-based, with end-to-end data encryption, double authentication, and deliberately deactivated camera, microphone, and GSM modules on the robot for child safety and data minimization.

The company has built clinical evidence through the Asthma JOECARE study, a randomized Phase 3 trial conducted across 17 French hospital and private centers following 213 children aged 4-11 with moderate-to-severe persistent asthma over 12 months, demonstrating a reduction in severe asthma exacerbations in children aged 7-11. A two-year real-world early access program in 2023-2024 equipped over 750 children with JOE through 150 prescribing physicians, with 96% of 53 surveyed ambassador physicians recommending the product and family satisfaction scored 7.5/10. The April 2026 favorable opinion from France's Haute Autorité de Santé (HAS), the first ever for a mobile application in pediatric asthma, opens the path to national reimbursement, subject to a Ministry of Health decision and price agreement.

Ludocare operates a sales-led, prescription-driven go-to-market: JOE is prescribed by pediatricians, pulmonologists, and general practitioners, and Ludocare monetizes through a subscription rental model (one-time annual or monthly recurring payment) covering the robot device and the parent app activation code, distributed through its own e-commerce storefront (shop.ludocare.com) and a commercial partnership with VIATRIS for national rollout in France. The product is also offered as a D2C subscription outside the prescription pathway, with a 30-day satisfaction-or-refund guarantee. Operational certifications include ISO 13485:2016+A11:2021 for medical device quality management, ISO/IEC 27001:2022 for information security, and GDPR compliance with EU-hosted data.

Short descriptiontext

Ludocare is a French digital health company developing JOE, a prescription digital therapeutic for pediatric asthma that combines a connected companion robot with a parent mobile app to improve treatment adherence, with regulatory clearance, Phase 3 clinical evidence, and a national rollout via VIATRIS.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersLyon, France
HQ citystring
Lyon
HQ countrystring
France
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pediatric digital therapeutics, connected medical devices, asthma management solutions, companion robot healthcare, digital health subscriptions
Industry2 codes
1Condition-specific Digital Therapeutics (DTx)
CodeHLACANAAPrimaryYes
2Pediatrics & Adolescent Therapeutics (Digital)
CodeHLACANALPrimaryNo
NAICS code1 code
  • Home Health Equipment Rental532283
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
Pediatric Digital Therapeutics
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Subscription-Based Robot Rental (Abonnement)
TypeSubscription Recurring
Description

Ludocare provides its solution (robot companion + mobile application) through a rental subscription model. Customers subscribe to an Abonnement which includes: (1) provision of a JOE or LEO robot in rental, and (2) an access code to activate the companion mobile application. Subscriptions are available with one-time annual payment or monthly recurring payment. The robot remains the property of LUDOCARE throughout the subscription. A 14-day right of retraction and a 30-day 'Satisfied or Refunded' guarantee are offered.

ludocare.com
2Reimbursement Pathway via French Health System
TypeSubscription Recurring
Description

JOE Digital Therapeutic is a Class I medical device under EU Regulation 2017/745 bearing CE marking. France's Haute Autorité de Santé (HAS) issued a favorable opinion (April 2026) recognizing sufficient expected service for pediatric asthma treatment in France, opening the path to national reimbursement. Reimbursement will be granted after a decision by the Ministry of Health and a price agreement is reached.

ludocare.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations
Pricing details2 tiers
1Annual Subscription - One-Time Payment
ModelSubscriptionBilling cadenceMulti-year contract
Notes

One-time payment for the full annual subscription duration. Includes robot rental and application access code.

ludocare.com
2Monthly Recurring Subscription
ModelSubscriptionBilling cadenceMonthly
Notes

Monthly payment according to an e-chelon schedule provided in the order confirmation email and available in the customer account area. Customers can terminate at any time after the initial engagement period.

ludocare.com
GTM typeB2C
B2C
Offering typeServices
Services
Brand1 of 2 records shown
1JOE
Description

Digital therapeutic (DTx) for pediatric asthma management, combining an interactive companion robot with integrated screen and parent app

ludocare.com
+1 more record
Core offering1 text field

Ludocare develops and markets pediatric Digital Therapeutics (DTx), with its flagship product JOE being a connected medical device for pediatric asthma management. The offering combines a physical companion robot with an integrated screen and a parent mobile application, delivered on medical prescription and via subscription rental to improve treatment adherence and inhalation technique in children aged 4-11 with persistent asthma.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Reduced number of severe asthma exacerbations in children aged 7-11 years (Asthma JOECARE Phase 3 clinical trial, 213 children, 17 centers, 12 months)
+2 more records
Product overview1 text field

Ludocare is a French digital health company and pioneer in pediatric Digital Therapeutics, offering an integrated ecosystem consisting of companion robots (JOE and LEO) and a parent mobile application. The flagship product, JOE Digital Therapeutic, is a Class I medical device combining an interactive robot companion with an integrated screen and a dedicated parent smartphone app. This solution is prescribed for children with persistent asthma and operates as a subscription-based service, with the robot provided via rental and the app downloadable from App Store and Google Play. The system aims to improve treatment adherence and reduce severe asthma exacerbations through age-appropriate education, medication reminders, and gamified engagement.

Product and service3 records
1JOE Digital Therapeutic
CategoryDigital Therapeutics
Description

A prescription-based digital therapeutic (DTx) combining an interactive companion robot with an integrated screen and a parent mobile app, designed to improve treatment adherence and help children aged 4-11 with persistent asthma gain autonomy in managing their condition. Delivered as a Class I CE-marked medical device.

2JOE Companion Robot
CategoryConnected Medical Device
Description

A connected companion device for children that reminds them to take medications, guides proper inhalation techniques through interactive multimedia content, and rewards adherence with personalized feedback. Provided via rental subscription.

3Ludocare Parent Mobile Application
Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership12 partners
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2022-12-01
Description

Ludocare and VIATRIS announced a commercial partnership in December 2022 for the rollout of JOE Digital Therapy in France. VIATRIS supports the commercial deployment and market access of JOE, leveraging its pharmaceutical distribution network and healthcare professional relationships in France.

Strategic tierMinorTypeOthers
Description

INOV is listed among Ludocare's supporters, appearing in the supporters section of the company website alongside other healthcare innovation ecosystem partners.

Strategic tierMinorTypeOthers
Description

Listed as a supporter with the i-Lab logo, indicating MESRI's support for Ludocare's innovation and research activities through national research and innovation programs.

Strategic tierMinorTypeOthers
Description

SNITEM, the French trade association for medical technology companies, is listed as a supporter of Ludocare, indicating industry association membership and representation.

Strategic tierMinorTypeOthers
Description

France Biotech, the French association for health innovation companies, is listed as a supporter of Ludocare, indicating membership in the health biotech/medtech ecosystem.

Strategic tierMinorTypeOthers
Description

Lyonbiopole, the competitive cluster for health innovation in the Lyon region, is listed as a supporter of Ludocare. The company is based in the Lyon area (Ecully), indicating regional innovation ecosystem support.

Strategic tierMinorTypeOthers
Description

Viaris is listed among Ludocare's supporters on the company website, indicating a supporting partner in the healthcare ecosystem.

Strategic tierMinorTypeOthers
Description

BayaM is listed among Ludocare's partners, appearing in the partners section of the website alongside other partner organizations.

Strategic tierMinorTypeOthers
Description

Billy the Cast is listed among Ludocare's partners, indicating a content or entertainment partnership related to the digital therapeutic experience for children.

Strategic tierMinorTypeOthers
Description

CANOPE, the network for educational resources and cultural activities for schools in France, is listed among Ludocare's partners, indicating an educational content collaboration.

Strategic tierMinorTypeOthers
Description

CNRS, France's national scientific research center, is listed among Ludocare's partners, indicating potential research collaboration or scientific advisory support.

Strategic tierMinorTypeOthers
Description

Victorie is listed among Ludocare's partners on the company website, indicating a collaborative partnership in the healthcare or innovation ecosystem.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Market position
Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers15 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Ludocare

Pediatric Digital Therapeuticsludocare.com

Ludocare is a French digital health company developing JOE, a prescription digital therapeutic for pediatric asthma that combines a connected companion robot with a parent mobile app to improve treatment adherence, with regulatory clearance, Phase 3 clinical evidence, and a national rollout via VIATRIS.

What Ludocare does

Ludocare is a French digital health company founded in Lyon in 2017 that develops prescription digital therapeutics for children with chronic conditions, with a current focus on persistent pediatric asthma. Its flagship product, JOE, is a Class I CE-marked medical device consisting of two integrated components: a connected companion robot with an integrated screen that delivers medication reminders, guides inhalation technique via interactive multimedia content, and rewards adherence; and a parent-facing mobile application that enables individualized treatment configuration and real-time monitoring of medication intake, with optional caregiver profiles for shared monitoring. The platform is Android-based, with end-to-end data encryption, double authentication, and deliberately deactivated camera, microphone, and GSM modules on the robot for child safety and data minimization.

The company has built clinical evidence through the Asthma JOECARE study, a randomized Phase 3 trial conducted across 17 French hospital and private centers following 213 children aged 4-11 with moderate-to-severe persistent asthma over 12 months, demonstrating a reduction in severe asthma exacerbations in children aged 7-11. A two-year real-world early access program in 2023-2024 equipped over 750 children with JOE through 150 prescribing physicians, with 96% of 53 surveyed ambassador physicians recommending the product and family satisfaction scored 7.5/10. The April 2026 favorable opinion from France's Haute Autorité de Santé (HAS), the first ever for a mobile application in pediatric asthma, opens the path to national reimbursement, subject to a Ministry of Health decision and price agreement.

Ludocare operates a sales-led, prescription-driven go-to-market: JOE is prescribed by pediatricians, pulmonologists, and general practitioners, and Ludocare monetizes through a subscription rental model (one-time annual or monthly recurring payment) covering the robot device and the parent app activation code, distributed through its own e-commerce storefront (shop.ludocare.com) and a commercial partnership with VIATRIS for national rollout in France. The product is also offered as a D2C subscription outside the prescription pathway, with a 30-day satisfaction-or-refund guarantee. Operational certifications include ISO 13485:2016+A11:2021 for medical device quality management, ISO/IEC 27001:2022 for information security, and GDPR compliance with EU-hosted data.

Ludocare firmographics

Firmographics
Name
Ludocare
Legal name
LUDOCARE
Website
https://ludocare.com
Company type
Private
Founded year
2017
Operating status
Operating
Headcount range
11–50 employees
Short description
Ludocare is a French digital health company developing JOE, a prescription digital therapeutic for pediatric asthma that combines a connected companion robot with a parent mobile app to improve treatment adherence, with regulatory clearance, Phase 3 clinical evidence, and a national rollout via VIATRIS.
Ownership category
akta.pro rank

Ludocare industry classification

Industry
Product category
Pediatric Digital Therapeutics
NAICS
Home Health Equipment Rental (532283)
SIC
Surgical & Medical Instruments & Apparatus (3841)
akta.pro primary industry
Condition-specific Digital Therapeutics (DTx) (HLACANAA)
akta.pro secondary industry
Pediatrics & Adolescent Therapeutics (Digital) (HLACANAL)

Keywords

  • Pediatric digital therapeutics
  • Connected medical devices
  • Asthma management solutions
  • Companion robot healthcare
  • Digital health subscriptions

Where Ludocare is headquartered

Location

Headquarters

HQ city
Lyon
HQ country
France
HQ region
Europe

Offices1 record

Markets served

Ludocare business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations

Revenue model

  1. Subscription-Based Robot Rental (Abonnement): Ludocare provides its solution (robot companion + mobile application) through a rental subscription model. Customers subscribe to an Abonnement which includes: (1) provision of a JOE or LEO robot in rental, and (2) an access code to activate the companion mobile application. Subscriptions are available with one-time annual payment or monthly recurring payment. The robot remains the property of LUDOCARE throughout the subscription. A 14-day right of retraction and a 30-day 'Satisfied or Refunded' guarantee are offered.
  2. Reimbursement Pathway via French Health System: JOE Digital Therapeutic is a Class I medical device under EU Regulation 2017/745 bearing CE marking. France's Haute Autorité de Santé (HAS) issued a favorable opinion (April 2026) recognizing sufficient expected service for pediatric asthma treatment in France, opening the path to national reimbursement. Reimbursement will be granted after a decision by the Ministry of Health and a price agreement is reached.

Pricing tiers

ModelBillingPrice
SubscriptionMulti-year contractAnnual Subscription - One-Time Payment
SubscriptionMonthlyMonthly Recurring Subscription

Go-to-market motion1 record

Distribution channels4 records

Marketing channels7 records

Ludocare product offering

Product offering

Core offering

Ludocare develops and markets pediatric Digital Therapeutics (DTx), with its flagship product JOE being a connected medical device for pediatric asthma management. The offering combines a physical companion robot with an integrated screen and a parent mobile application, delivered on medical prescription and via subscription rental to improve treatment adherence and inhalation technique in children aged 4-11 with persistent asthma.

Product overview

Ludocare is a French digital health company and pioneer in pediatric Digital Therapeutics, offering an integrated ecosystem consisting of companion robots (JOE and LEO) and a parent mobile application. The flagship product, JOE Digital Therapeutic, is a Class I medical device combining an interactive robot companion with an integrated screen and a dedicated parent smartphone app. This solution is prescribed for children with persistent asthma and operates as a subscription-based service, with the robot provided via rental and the app downloadable from App Store and Google Play. The system aims to improve treatment adherence and reduce severe asthma exacerbations through age-appropriate education, medication reminders, and gamified engagement.

Differentiator

Problem solved

Functional benefit

Brands

  • JOE: Digital therapeutic (DTx) for pediatric asthma management, combining an interactive companion robot with integrated screen and parent app
  • LEO

Products and services

  • JOE Digital Therapeutic A prescription-based digital therapeutic (DTx) combining an interactive companion robot with an integrated screen and a parent mobile app, designed to improve treatment adherence and help children aged 4-11 with persistent asthma gain autonomy in managing their condition. Delivered as a Class I CE-marked medical device.
  • JOE Companion Robot A connected companion device for children that reminds them to take medications, guides proper inhalation techniques through interactive multimedia content, and rewards adherence with personalized feedback. Provided via rental subscription.
  • Ludocare Parent Mobile Application

Quantifiable outcome

  • Reduced number of severe asthma exacerbations in children aged 7-11 years (Asthma JOECARE Phase 3 clinical trial, 213 children, 17 centers, 12 months)
  • +2 more outcomes

Companies that use Ludocare

Customer profile

Named customers15 records

Segments3 records

Ideal customer profiles2 records

Ludocare technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Ludocare partnerships and signals

Strategic signal

Partnerships

Twelve partnerships are on record, tiered core and minor.

  • VIATRIScoreChannel Partner/ Reseller/ Distributor · 1 December 2022Ludocare and VIATRIS announced a commercial partnership in December 2022 for the rollout of JOE Digital Therapy in France. VIATRIS supports the commercial deployment and market access of JOE, leveraging its pharmaceutical distribution network and healthcare professional relationships in France.
  • INOVminorOthersINOV is listed among Ludocare's supporters, appearing in the supporters section of the company website alongside other healthcare innovation ecosystem partners.
  • MESRI (Ministère de l'Enseignement Supérieur, de la Recherche et de l'Innovation)minorOthersListed as a supporter with the i-Lab logo, indicating MESRI's support for Ludocare's innovation and research activities through national research and innovation programs.
  • SNITEM (Syndicat National de l'Industrie des Technologies Médicales)minorOthersSNITEM, the French trade association for medical technology companies, is listed as a supporter of Ludocare, indicating industry association membership and representation.
  • France BiotechminorOthersFrance Biotech, the French association for health innovation companies, is listed as a supporter of Ludocare, indicating membership in the health biotech/medtech ecosystem.
  • LyonbiopoleminorOthersLyonbiopole, the competitive cluster for health innovation in the Lyon region, is listed as a supporter of Ludocare. The company is based in the Lyon area (Ecully), indicating regional innovation ecosystem support.
  • ViarisminorOthersViaris is listed among Ludocare's supporters on the company website, indicating a supporting partner in the healthcare ecosystem.
  • BayaMminorOthersBayaM is listed among Ludocare's partners, appearing in the partners section of the website alongside other partner organizations.
  • Billy the CastminorOthersBilly the Cast is listed among Ludocare's partners, indicating a content or entertainment partnership related to the digital therapeutic experience for children.
  • CANOPEminorOthersCANOPE, the network for educational resources and cultural activities for schools in France, is listed among Ludocare's partners, indicating an educational content collaboration.
  • CNRS (Centre National de la Recherche Scientifique)minorOthersCNRS, France's national scientific research center, is listed among Ludocare's partners, indicating potential research collaboration or scientific advisory support.
  • VictorieminorOthersVictorie is listed among Ludocare's partners on the company website, indicating a collaborative partnership in the healthcare or innovation ecosystem.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Ludocare competitors and assessment

Company assessment

Market position

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Ludocare social profiles

Digital presence

Ludocare compliance and trust

Trust signal

Compliance4 records

Ludocare financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Ludocare leadership team

Management profile

Number of profiles

Profiles2 records

Ludocare funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Ludocare M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ludocare

What does Ludocare do?

Ludocare develops and markets pediatric Digital Therapeutics (DTx), with its flagship product JOE being a connected medical device for pediatric asthma management. The offering combines a physical companion robot with an integrated screen and a parent mobile application, delivered on medical prescription and via subscription rental to improve treatment adherence and inhalation technique in children aged 4-11 with persistent asthma.

Is Ludocare a public or private company?

Ludocare is a private company. It is classified as venture growth investor backed and is currently operating.

When was Ludocare founded?

Ludocare was founded in 2017. It employs 11 to 50 people.

Where is Ludocare based?

Ludocare is headquartered in Lyon, France, in the Europe region.

How does Ludocare make money?

Two revenue lines are on record. Subscription-Based Robot Rental (Abonnement) is the primary driver. The others are reimbursement Pathway via French Health System.

Does Ludocare have an API?

No public API is recorded for Ludocare.

What industry is Ludocare in?

Ludocare's product category is Pediatric Digital Therapeutics. Its primary akta.pro industry code is HLACANAA, Condition-specific Digital Therapeutics (DTx), with a secondary code of HLACANAL, Pediatrics & Adolescent Therapeutics (Digital). Its NAICS code is 532283 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
MaddynessPremier avis favorable pour le remboursement de la thérapie numérique Joe de la startup LudocareFrance's Haute autorité de santé (HAS) issued a favorable opinion for the reimbursement of Ludocare's digital therapy Joe, marking the first time a mobile application has been recognized as providing sufficient expected service for pediatric asthma treatment in France. The device combines an interactive robot with an integrated screen and a parent app to improve treatment adherence and help children aged 7 to 11 gain autonomy. Reimbursement will only be granted after a decision by the Ministry of Health and a price agreement is reached.Tech.euLyon-based Ludocare tucks in €4.2 million to boost asthma care in kidsFrench digital therapy company Ludocare secured €4.2 million in funding from investors Karista and Bpifrance to address low asthma treatment compliance in children. The capital will be used to launch a clinical study and implement a medical prescription strategy for its connected robot companion designed to improve pediatric medication adherence.LudocareEspace presse – LudocareLudocare announced that the Haute Autorité de Santé (HAS) has recognized its digital therapy JOE as having a sufficient expected service, paving the way for its reimbursement. This recognition demonstrates the potential for broader adoption of the therapy in the healthcare market. Additionally, Ludocare has received the ISO/IEC 27001:2022 certification, reinforcing its commitment to health data security and cybersecurity.